-
Overview
Biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and gene therapy vectors are transforming modern medicine.
However, manufacturing these complex biologics remains challenging.
Our research integrates cell engineering and bioprocess strategies to develop next-generation manufacturing platforms for advanced therapeutics. -
Key Research Areas
Engineering Mammalian Production Hosts
We develop optimized mammalian cell lines capable of producing complex biologics with improved productivity and robustness.
Next-Generation Biologics Manufacturing PlatformsOur research focuses on enabling scalable production of emerging therapeutic modalities, including complex proteins and gene therapy vectors.
Data-Driven Bioprocess OptimizationWe integrate high-throughput experimentation and data analysis to improve manufacturing efficiency and process reliability.
-
Vision
Our goal is to enable scalable, programmable, and efficient manufacturing platforms for next-generation biotherapeutics.
